ASBMR 2018

Bone Mineral Density Improved With Intravenous Ibandronate in Osteoporosis

Bone Mineral Density Improved With Intravenous Ibandronate in Osteoporosis

By

Investigators assessed the effectiveness of intravenous ibandronate on bone mineral density in patients with osteoporosis who did not respond to oral bisphosphonates.

Incident Vertebral Fracture Risk in Former, Current Smokers With or Without COPD

Incident Vertebral Fracture Risk in Former, Current Smokers With or Without COPD

By

Bone attenuation was found to be an independent determinant for vertebral fractures in former smokers with and without chronic obstructive pulmonary disease.

Glucocorticoids Linked to Significant Bone Deficit in Pediatric Crohn Disease

Glucocorticoids Linked to Significant Bone Deficit in Pediatric Crohn Disease

By

Glucocorticoid therapy was linked to significant bone deficits across multiple axial sites, regardless of disease activity.

MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of Fracture

MicroRNAs Linked to Increased Cortical Bone Porosity in Postmenopausal Women With History of Fracture

By

Findings suggest potential pathomechanistic links between miRNAs and cortical porosity. .

Bone Mineral Density Changes After Anastrozole in Postmenopausal Women

Bone Mineral Density Changes After Anastrozole in Postmenopausal Women

By

In postmenopausal women who were randomly assigned anastrozole, bone mineral density showed significant improvement at the lumbar spine.

Effects of Vitamin D3 Treatment on Bone Strength in Postmenopausal Women

Effects of Vitamin D3 Treatment on Bone Strength in Postmenopausal Women

By

Investigators sought to determine the effects of vitamin D3 supplementation in postmenopausal women with low serum 25(OH)D and high parathyroid hormone levels.

Early Life Exposures Affect Bone Density in Young Adulthood

Early Life Exposures Affect Bone Density in Young Adulthood

By

Early life exposures, such as maternal smoking and breastfeeding, may have effects on bone mineral density in young adulthood.

Drug Holidays May Reduce Risk for Atypical Femur Fracture

Drug Holidays May Reduce Risk for Atypical Femur Fracture

By

Bisphosphonate holidays of 3 to 5 years have been recommended as a means of achieving the antifracture benefit of the medication.

Sign Up for Free e-Newsletters



CME Focus